Cyclobenzaprine Hydrochloride
Product Images NDC 53002-0522

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 53002-0522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclobenzaprine Hydrochloride Structural Formula (Image 1)

Chemical structure of Cyclobenzaprine Hydrochloride, showing the molecular framework with rings and functional groups including an HCl component.*

FDA Label Image

Label Image (Lbl530020522)

Cyclobenzaprine 5 mg tablets prescription label from RPK Pharmaceuticals, Inc. The package contains 30 tablets. Instructions indicate to take 1 tablet three times a day as needed or as directed. The label includes patient and prescriber information fields, lot number, expiration date, and billing NDC details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.